Holen Sie sich die Stockscreener-App
63.30
0.78%
-0.50
Handel nachbörslich:
63.52
0.22
+0.35%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$63.80
Offen:
$63.25
24-Stunden-Volumen:
7.35M
Relative Volume:
0.86
Marktkapitalisierung:
$80.08B
Einnahmen:
$378.96B
Nettoeinkommen (Verlust:
$5.28B
KGV:
15.11
EPS:
4.19
Netto-Cashflow:
$5.94B
1W Leistung:
-3.54%
1M Leistung:
-5.65%
6M Leistung:
+20.30%
1J Leistung:
+2.76%
1-Tages-Spanne:
$62.48
$63.88
1-Wochen-Bereich:
$62.48
$65.24
52-Wochen-Spanne:
$43.56
$72.51
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Vergleichen Sie CVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
63.30 | 83.01B | 378.96B | 5.28B | 5.94B | 4.19 |
|
UNH
Unitedhealth Group Inc
|
288.07 | 271.70B | 410.06B | 22.11B | 24.86B | 23.88 |
|
CI
Cigna Group
|
298.28 | 82.49B | 254.47B | 5.03B | 6.01B | 18.06 |
|
ELV
Elevance Health Inc
|
302.45 | 78.14B | 183.12B | 5.92B | 3.67B | 25.63 |
|
HUM
Humana Inc
|
223.55 | 28.02B | 117.76B | 1.21B | 2.39B | 9.95 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
$95M Caremark Verdict Should Put PBMs On Notice - Law360
The National Observer: Pharmacies closing at an alarming rate - The Business Journals
Cwm LLC Grows Position in CVS Health Corporation (NYSE:CVS) - MarketBeat
CVS Health Corporation (NYSE:CVS) Stake Reduced by Pzena Investment Management LLC - MarketBeat
CVS Health's Q2 2025 Earnings: What to Expect - Yahoo Finance
Welch & Forbes LLC Sells 7,133 Shares of CVS Health Corporation (NYSE:CVS) - MarketBeat
Sigma Planning Corp Sells 6,320 Shares of CVS Health Corporation (NYSE:CVS) - MarketBeat
Kathmere Capital Management LLC Invests $269,000 in CVS Health Corporation (NYSE:CVS) - MarketBeat
CVS Health Corporation (NYSE:CVS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
CVS Health swaps underlying small-cap value managers in 401(k) plan - Pensions & Investments
CVS Health's Q2 2025 Earnings: What To Expect - Barchart.com
4 Value Stocks to Buy as Inflation and Market Volatility Rise - Yahoo Finance
DDD Partners LLC Acquires Shares of 180,442 CVS Health Corporation (NYSE:CVS) - MarketBeat
Allworth Financial LP Acquires 4,030 Shares of CVS Health Corporation (NYSE:CVS) - MarketBeat
Signaturefd LLC Boosts Holdings in CVS Health Corporation (NYSE:CVS) - MarketBeat
Fort Sheridan Advisors LLC Reduces Stake in CVS Health Corporation (NYSE:CVS) - MarketBeat
John Dorfman: CVS, Archer-Daniels look good on this ratio - TribLIVE.com
29,689 Shares in CVS Health Corporation (NYSE:CVS) Purchased by Cornercap Investment Counsel Inc. - MarketBeat
CVS Health Corporation (NYSE:CVS) Shares Sold by Mountain Hill Investment Partners Corp. - MarketBeat
Catalyst Financial Partners LLC Makes New Investment in CVS Health Corporation (NYSE:CVS) - MarketBeat
Axxcess Wealth Management LLC Invests $695,000 in CVS Health Corporation (NYSE:CVS) - MarketBeat
CVS Opens First of 64 Former Rite Aid Stores in the Pacific Northwest - Connect CRE
Aetna, CVS Can't Dodge $21M Payment Battle, Lab Says - Law360
CVS Up on Medicare Advantage Strength: Is It a Buy Before Q2 Earnings? - Yahoo Finance
AI Healthtech Firm Partners with EngageWell & CVS Health Foundation on NYC Senior Care Initiative - streetwisereports.com
Jefferies Maintains ‘Buy’ Rating on CVS Health Corporation (CVS); Raises PT - Insider Monkey
Mutual of America Capital Management LLC Has $9.96 Million Stake in CVS Health Corporation (NYSE:CVS) - MarketBeat
Leerink Partnrs Forecasts Stronger Earnings for CVS Health - MarketBeat
LRI Investments LLC Has $959,000 Position in CVS Health Corporation (NYSE:CVS) - MarketBeat
Arizona State Retirement System Has $25.02 Million Stake in CVS Health Corporation (NYSE:CVS) - MarketBeat
Concurrent Investment Advisors LLC Decreases Stake in CVS Health Corporation (NYSE:CVS) - MarketBeat
Nisa Investment Advisors LLC Acquires 26,981 Shares of CVS Health Corporation (NYSE:CVS) - MarketBeat
Fidelis Capital Partners LLC Has $894,000 Position in CVS Health Corporation (NYSE:CVS) - MarketBeat
Brown Advisory Inc. Has $6.68 Million Position in CVS Health Corporation (NYSE:CVS) - MarketBeat
M&T Bank Corp Sells 17,012 Shares of CVS Health Corporation (NYSE:CVS) - MarketBeat
Topsail Wealth Management LLC Acquires New Stake in CVS Health Corporation (NYSE:CVS) - MarketBeat
CVS opens first of 64 PNW stores acquired from Rite Aid - The Business Journals
District Court Orders CVS Caremark to Pay U.S. Government $95 Million - JD Supra
Dividend Roundup: CVS Health, Procter & Gamble, AbbVie, Colgate-Palmolive, and more (PG:NYSE) - Seeking Alpha
CVS Health (CVS) is quietly staging comeback after losing 900 stores and 60% of its value - Investorsobserver
4,644 Shares in CVS Health Corporation (NYSE:CVS) Bought by Beverly Hills Private Wealth LLC - MarketBeat
CVS Health plans to appeal $948.8 million judgement - Yahoo
CVS Launches Virtual Health Program for Seniors in New York City | CVS Stock News - GuruFocus
CVS Launches Virtual Health Program for Seniors in New York City - GuruFocus
Report: Federal judge orders CVS’ Omnicare to pay $949M for fraudulent prescriptions - Providence Business News
Bank of New York Mellon Corp Buys 183,813 Shares of CVS Health Corporation (NYSE:CVS) - MarketBeat
Judge orders CVS to pay nearly $1B in Omnicare lawsuit - The Business Journals
CVS Health Fined Nearly $1 Billion Over Drug Billing Fraud - Finimize
Here's Why CVS Health (CVS) is a Strong Value Stock - Yahoo Finance
Is CVS Moving Closer to Reaching Its Long-Term Low 3X Leverage Goal? - Yahoo Finance
3,844 Shares in CVS Health Corporation (NYSE:CVS) Purchased by Callan Capital LLC - MarketBeat
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):